🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT06775288
Active, not recruiting Not applicable

Hypoglycemia Prevention and Awareness Program

NCT06775288 · tracked via the Priya Life Science Turkey tracker
Sponsor
Merve DerviAYoAYlu
Phase
Not applicable
Started
2024-11-01
Last updated
2025-01-15

Condition(s) studied

DiabetesHypocalcemiaTelehealthNursing CareNursing Education

Investigational drug(s) / intervention(s)

Hypoglycemia prevention and awareness program (HypoPAP)

Hypoglycemia prevention and awareness program (HypoPAP): Online hypoglycemia prevention and awareness training Supporting the prevention of hypoglycemia with the use of evidence-based diabetes-friendly plates Encouraging physical activity and supporting glycemic control with a pedometer Filling in a weekly problem-solving notebook Conducting weekly online problem-solving meetings Online counseling service when needed

Study summary

The aim of this project is to examine the effects of the Hypoglycemia Prevention and Awareness Program (HypoPAP) on patient outcomes, including metabolic, psychological, social, and economic parameters, in individuals with type 2 diabetes and impaired hypoglycemia awareness.

Through the interventions provided to participants, the study aims to achieve the following improvements:

* Physiological parameters: Enhanced glycemic control, reduced hypoglycemia frequency, improved hypoglycemia awareness, and optimized HbA1c levels.
* Psychological parameters: Reduced fear of hypoglycemia, increased hypoglycemic confidence, and improved attitudes toward hypoglycemia management.
* Social parameters: Decreased social withdrawal due to fear of hypoglycemia, as assessed through relevant items in validated scales.
* Economic parameters: Reduced frequency of hospitalizations and emergency department visits.

Overall, the program seeks to enhance participants' ability to prevent and manage hypoglycemia, thereby improving their overall well-being.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Being 18 years of age and older * Being able to communicate in Turkish * Being diagnosed with type 2 diabetes * Having used insulin for at least one year * Having reduced hypoglycemia awareness * Being willing to participate in the study * Having and being able to use information technology products (telephone, computer). Exclusion Criteria: * Having visual, auditory, cognitive impairment * Having a condition that prevents communication * Not being able to use information technology products * Having chronic renal failure, chronic vascular disease, chronic liver disease, cancer * Pregnancy * Endocrine and eating disorders * Individuals who do not agree to participate in the study * Do not meet the inclusion criteria will not be included.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Dokuz Eylül University Izmir Turkey (Türkiye)

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06775288 on ClinicalTrials.gov ↗ ← All trials in Turkey